PRPO vs. RPID, AXDX, OMIC, TLIS, ASTC, HLTH, TBIO, HTGMQ, BNGO, and HBIO
Should you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Rapid Micro Biosystems (RPID), Accelerate Diagnostics (AXDX), Singular Genomics Systems (OMIC), Talis Biomedical (TLIS), Astrotech (ASTC), Cue Health (HLTH), Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), Bionano Genomics (BNGO), and Harvard Bioscience (HBIO). These companies are all part of the "analytical instruments" industry.
Precipio (NASDAQ:PRPO) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations, community ranking and institutional ownership.
In the previous week, Precipio and Precipio both had 2 articles in the media. Rapid Micro Biosystems' average media sentiment score of 1.44 beat Precipio's score of 1.43 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.
10.5% of Precipio shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 10.6% of Precipio shares are owned by insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Precipio has a net margin of -31.00% compared to Rapid Micro Biosystems' net margin of -224.73%. Rapid Micro Biosystems' return on equity of -42.25% beat Precipio's return on equity.
Precipio has higher earnings, but lower revenue than Rapid Micro Biosystems. Precipio is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
Precipio currently has a consensus price target of $40.00, suggesting a potential upside of 594.44%. Given Precipio's higher possible upside, equities analysts clearly believe Precipio is more favorable than Rapid Micro Biosystems.
Precipio has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500.
Precipio received 268 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 26.67% of users gave Rapid Micro Biosystems an outperform vote.
Summary
Rapid Micro Biosystems beats Precipio on 8 of the 15 factors compared between the two stocks.
Get Precipio News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precipio Competitors List
Related Companies and Tools
